Levetiracetam is an anticonvulsant medication used to treat epilepsy. Levetiracetam may selectively prevent hypersynchronization of epileptiform burst firing link propagation of seizure keppra drug bank. Levetiracetam binds to the synaptic vesicle protein SV2A, which is thought to be involved in the regulation bank vesicle exocytosis.
Although the molecular significance of levetiracetam binding to synaptic vesicle protein SV2A is not understood, levetiracetam and related analogs keppra drug bank a rank order of affinity for SV2A which correlated with the potency of their antiseizure activity in audiogenic seizure-prone mice.
keppra drug bank Used as adjunctive therapy in the treatment of partial onset seizures in adults and children 4 years of age and older with epilepsy. The precise mechanism s by which levetiracetam keppra drug bank its antiepileptic effect bank unknown. The antiepileptic activity of levetiracetam was assessed in a number of animal models of epileptic seizures.
Levetiracetam did not inhibit single seizures induced by maximal stimulation with electrical current or different chemoconvulsants and showed bank minimal activity in submaximal stimulation and in threshold tests. Protection was observed, bank, against secondarily generalized activity from focal seizures induced by keppra drug bank and kainic acid, two chemoconvulsants that keppra drug bank seizures that mimic some features of human complex partial seizures with secondary generalization.
Levetiracetam also displayed inhibitory properties in the kindling model in rats, another model of human complex partial keppra drug bank, both during kindling development and in the fully kindled state.
The predictive value of these animal models for specific types of human epilepsy is uncertain. Levetiracetam is thought to stimulate synaptic vesicle protein 2A SV2Ainhibiting neurotransmitter release.
Peak plasma concentrations occurring in about an hour following keppra drug bank /abilify-what-is-it-year.html in fasted subjects.
No CYP metabolism detected. The metabolites have keppra drug bank known pharmacological activity keppra drug bank are renally excreted.
The mechanism of excretion is glomerular filtration with subsequent partial tubular reabsorption. Keppra drug bank effects include aggression, agitation, coma, drowsiness, reduced consciousness, slowed breathing.
Patent US, issued September, keppra drug bank Drug created on Keppra drug bank 13, Levetiracetam Targets 2 Enzymes 1 Transporters 2 Keppra drug bank 5. Drug Interaction R -warfarin Keppra drug bank metabolism of R -warfarin can be decreased when combined with Levetiracetam.
Abafungin Keppra drug therapeutic efficacy of Abafungin can be increased when used in combination keppra keppra drug bank bank Levetiracetam. Abatacept The metabolism of Levetiracetam can be increased when combined with Abatacept.
Abemaciclib Here serum concentration of Keppra drug can be increased when it is combined with Abemaciclib.
2018 ©